Dr Khoo is currently the Deputy Director-General of Health (DDGH), Appropriate and Value-Based Care (AVBC). She oversees the establishment and formalization of Appropriate and Value-Based Care (AVBC) framework. The framework seeks to improve and optimize clinical outcomes within available resources.

Dr Khoo was previously the Deputy Director-General of Health (Healthcare Performance Group). She leads the Ministry of Health’s teams which oversee Patient Safety, Clinical Outcomes, Value Driven Care, Population Health Indicators, Healthcare System Indicators and the National Improvement Unit. Under her leadership, she founded the Agency for Care Effectiveness (ACE) and was its first and current Executive Director. ACE is Singapore’s national Healthcare Technology Agency which conducts clinical evaluation and assess the cost effectiveness of drugs and device classes prior to subsidies coverage decisions by the Ministry of Health (MOH). ACE also issues MOH’s Appropriate Care Guides which guide clinical practice nationally.

Dr Khoo received her Endocrinology training at the Singapore General Hospital and the Cleveland Clinic, USA. She spent earlier years of her career in clinical and translational research, as well as in the private sector. As Chief Medical Officer, Fortis Healthcare, she had responsibilities in 11 countries including India and Vietnam. She is a Past President of the Endocrine and Metabolic Society, Singapore, ASEAN Federation of Endocrine Societies as well as the Association of Women Doctors, Singapore.

Professor Mak is the principal medical adviser to the Singapore Government and provides professional input and guidance to other Ministries and public agencies on health and healthcare related issues.

Professor Mak oversees the provision of all health services in Singapore. Within the Ministry of Health, he ensures that clinical services are delivered seamlessly across multiple settings by the public healthcare system. He leads in developing and implementing national healthcare policies in areas such as population health, healthcare regulation, communicable diseases and non-communicable diseases, healthcare professional standards as well as the development and enhancement of the performance of the nation’s healthcare system and services. Professor Mak works closely with Singapore’s Regional Health Systems and healthcare institutions on care integration as well as on Singapore’s long-term healthcare transformation strategy.

During the COVID-19 pandemic, Professor Mak advised the Multi-Ministry Taskforce as well as other governmental agencies in crafting Singapore’s overall strategy for managing the outbreak and oversaw the integrated public health response to control the spread of COVID-19 in our community. Professor Mak is a familiar face in Singapore as he appeared regularly in the media conferences of the COVID-19 Multi-Ministry Taskforce.

Professor Mak is the Registrar of the Singapore Medical Council, which is the Professional Board that ensures that medical practitioners, registered for clinical practice in Singapore, are competent and fit to practice medicine, upholding high standards of clinical practice and maintaining public confidence in the medical profession.

Professor Mak is a general surgeon with subspecialty interests in hepatobiliary and pancreatic surgery, as well as in trauma surgery. He maintains his clinical practice as a Senior Consultant surgeon in the Department of Surgery, at Khoo Teck Puat Hospital, Singapore. His previous administrative appointments included Chief of Surgery at three public hospitals in Singapore and Chairman of the Medical Board at Khoo Teck Puat Hospital, Singapore.

Professor Mak retired from voluntary military service in 2021, as a Colonel with the Singapore Armed Forces. He had held various command and staff appointments at Battalion, Brigade and Division level.

Ms Lau is currently the Deputy Secretary (Policy) at the Ministry of Health. This is her second stint at the Ministry of Health, where she also served between 2013 and 2019 in Healthcare Finance and oversaw the development and regulation of medical and long-term care insurance in Singapore.

From 2019 to 2021, she served as the Executive Director of the Singapore Global Network in the Economic Development Board. The Singapore Global Network coordinates and catalyses the Singapore Government’s efforts to strengthen Singapore’s overseas networks and talent strategies, and to enhance the international mindshare of Singapore as a leading and globally connected city.

Ms Lau has also held other appointments in the Ministry of Finance, the Ministry of Manpower and the Prime Minister’s Office. She holds Bachelor’s Degrees in both Economics and Bioengineering from the University of Pennsylvania, and a Master of Science in Technology and Policy from the Massachusetts Institute of Technology.

Outside of work, Ms Lau is learning the ropes as a mother of 2 babies. She plays netball and basketball when she can, and enjoys long runs that help her to destress.

Dr Morris is a social policy academic by profession who works as a Health Consumer Advocate and Representative. As a social scientist, she is committed to evidence-based policy and as a health consumer, she advocates for consumer perspectives in the design, delivery and evaluation of health research, policy and provision. Dr Morris has particular interests in the fields of cancer, person-centred care and health technology assessment. She has undertaken roles with multiple non-governmental and governmental organisations and committees including Australia’s Health Technology Assessment Consumer Consultative Committee, Breast Cancer Network of Australia, Consumers’ Health Forum of Australia and All.Can Australia and All.Can International.

Emeritus Professor Campbell AM MD DPhil FRACP was Professor of Medicine at St Vincent's Hospital, Sydney from 1998-2017, and was Deputy Dean of Medicine at UNSW (2006-17). He is a clinical cardiologist who trained in Internal Medicine and Cardiology at St Vincent’s Hospital and in Pharmacology at Oxford University. His own research has encompassed both basic laboratory research in cardiac pharmacology and clinical cardiology, and he has published over 120 peer-reviewed papers in these fields. His work has been cited over 5000 times.

He is a past-President of the Cardiac Society of Australia and New Zealand (2000-2), past Deputy Chair of the National Heart Foundation (NSW), and past Chair of the Therapeutics Advisory Committee of the Royal Australian College of Physicians (1996-2000). He served 15 years on the Pharmaceutical Benefits Advisory Committee (2001-16) and since 2016, has been Chair of the Medical Devices and Human Tissue Advisory Committee within the Australian Department of Health.

Professor Munn is an advocate for evidence-based healthcare and for ensuring policy and practice are based on the best available evidence. Professor Munn is the founding Director of Health Evidence Synthesis, Recommendations and Impact (HESRI) in the School of Public Health at the University of Adelaide; Head of the Evidence Synthesis Taxonomy Initiative (ESTI); Founding Director of the JBI Adelaide GRADE Centre; past-Chair of the Guidelines International Network (GIN) and a National Health and Medical Research Council (NHMRC) Investigator. He is a systematic review, evidence implementation and guideline development methodologist.

Adjunct Associate Professor Murphy graduated from the Royal College of Surgeons in Ireland and completed his Basic and Advanced Surgical Training in Orthopaedic Surgery in Ireland. During this time, he represented Irish Higher Surgical Trainees at a National level and was the Irish Orthopaedic representative on the Federation of Orthopaedic Trainees in Europe. He completed his fellowship training in Orthopaedic Trauma Surgery and joined the Department of Orthopaedic Surgery at the National University Hospital (NUH), Singapore in 2007. He is a Senior Consultant in the Musculoskeletal Trauma Division, NUH. He is actively involved in undergraduate and postgraduate teaching, is a clinical tutor at the NUS Yong Loo Lin School of Medicine and has published in numerous peer-reviewed journals.

Adjunct Associate Professor Murphy has been involved in Value Driven Healthcare since its introduction in Singapore by the NUH senior leadership. He was appointed Chief Value Officer for National University Hospital in 2018, Group Chief Value Officer for NUHS and Chairperson of the national Value-Driven Care Committee in 2019. He heads up a dedicated team that oversees and collects data on the quality and costs of care for specific medical and surgical conditions for each of the institutions within the NUHS cluster and provides updates on these conditions on a monthly basis to relevant stakeholders. He also oversees VBHC teaching and research as well as working with institutions on cost containment and sustainability.

Associate Professor Hairil is a Senior Consultant Anaesthesiologist at Singapore General Hospital (SGH). He revolutionized patient preparation for surgeries in SGH by founding the Preoperative Assessment Centre in 2014. His leadership in developing various programs like Patient Blood Management, Prehabilitation Service, and Enhanced Recovery After Surgery (ERAS) has garnered both national and international recognition.

Honoured with the prestigious Lee Kuan Yew Scholarship in 2022 and listed among the top 2% of globally cited scientists, Associate Professor Hairil was also awarded the Clinician Scientist Award by Singapore’s National Medical Research Council in 2023. He currently leads the Value-Based Healthcare initiatives in both SingHealth and SGH, and was awarded the “Distinguished Champion of Change Leader Award” by SingHealth in 2022 for his transformative contributions to healthcare.

Adjunct Professor Abisheganaden is a Director and Senior Consultant at Health Services and Outcomes Research (HSOR), National Healthcare Group (NHG). He holds a Fellowship from the Royal College of Physicians, Edinburgh UK; a MMED (Internal Medicine) from NUS Singapore, as well as a FAMS (Respiratory Med) from the Academy of Medicine Singapore. He leads the HSOR team in population decision analytics and operations research, implementation and outcomes evaluation, as well as health system performance and sustainability. He is also chair of the NHG Respiratory Health Steering Committee and an advisor to the NHG Value-Based Care team.